Results 101 to 110 of about 44,264 (223)
Pre-transplant amiodarone exposure is associated with increased mortality following cardiac transplantation: an analysis of the united network for organ sharing thoracic registry [PDF]
, 2003 Andrew D. Feingold +5 more
openalex +1 more source
Life cell imaging of amiodarone sequestration into lamellar bodies of alveolar type II cells
, 2023 Thomas Haller +3 more
openalex +1 more source
Clinical Endocrinology, Volume 104, Issue 2, Page 167-174, February 2026.ABSTRACT Objective To investigate the association between health literacy levels and biochemical control of hypothyroidism, measured by serum TSH and free thyroxine (FT4) levels, in patients receiving levothyroxine (L‐T4) therapy. Methods We conducted a cross‐sectional study at the Thyroid Disorders Outpatient Clinic, Escola Paulista de Medicina ...
Jessyka Krause Meneses +4 more
wiley +1 more source
Amiodarone Induced Thyrotoxicosis: A Case of Refractory Disease Treated With Thyroidectomy [PDF]
, 2021 Malek Mushref +2 more
openalex +1 more source
Clinical Transplantation, Volume 40, Issue 2, February 2026.ABSTRACT Background Postoperative atrial arrhythmia (POAA) is common after lung transplant, but data on its implications and management are limited. This study assessed POAA incidence and timing, its association with mortality and rehospitalizations, and outcomes related to postoperative beta‐blocker use.
Daniel M. Chen +11 more
wiley +1 more source
Efavirenz and CYP2C9 Genetic Polymorphisms Reduce CYP2C9 Activity in Healthy Participants
Clinical and Translational Science, Volume 19, Issue 2, February 2026.ABSTRACT Efavirenz's effects on cytochrome P450 2C9 (CYP2C9) activity have not been formally characterized in vivo. We conducted the first clinical drug–drug interaction (DDI) study to test the effect of chronic efavirenz dosing on CYP2C9 activity, using tolbutamide as a selective probe.
Jason D. Kim +4 more
wiley +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 935-945, February 2026.Abstract Aims To determine whether sodium glucose co‐transporter 2 inhibitors (SGLT2i) use, compared with dipeptidyl peptidase‐4 inhibitors (DPP4i) use, is associated with the risk of ventricular arrhythmias (VA) among patients with type 2 diabetes. Materials and Methods We conducted a population‐based cohort study using a prevalent new‐user design and
Wang‐Choi Tang +5 more
wiley +1 more source
Experimental Physiology, Volume 111, Issue 2, Page 474-488, 1 February 2026.Abstract Heart failure (HF) with a mildly reduced ejection fraction (HFmrEF; 40%–49%) is present in ≤25% of HF patients. Therapeutic treatment options for HFmrEF‐associated exercise intolerance are limited. Nitric oxide (NO)‐independent stimulation of soluble guanylyl cyclase to improve peripheral vasodilatation offers a novel approach to enhance ...
Ramona E. Weber +10 more
wiley +1 more source